[Management of cardiovascular comorbidities in immune-mediated inflammatory diseases].
In: La Revue de medecine interne, Jg. 45 (2024-04-01), Heft 4, S. 194-199
academicJournal
Zugriff:
Patients with chronic inflammatory and autoimmune diseases are at increased cardiovascular risk, which is the cause of persistent excess mortality despite increasingly effective specific treatment of the inflammatory and/or autoimmune disease. This increased cardiovascular risk is multifactorial, associated with accelerated atherosclerosis related to systemic inflammation, but also secondary to traditional cardiovascular risk factors and to the therapies used to control systemic inflammation. This justifies a coordinated, personalized management of cardiovascular risk in patients with chronic inflammatory and autoimmune diseases, based not only on the treatment of their disease to achieve the lowest level of activity, but also on the screening and management of their cardiovascular comorbidities and modifiable cardiovascular risk factors.
(Copyright © 2023 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.)
Titel: |
[Management of cardiovascular comorbidities in immune-mediated inflammatory diseases].
|
---|---|
Autor/in / Beteiligte Person: | Roubille, C |
Zeitschrift: | La Revue de medecine interne, Jg. 45 (2024-04-01), Heft 4, S. 194-199 |
Veröffentlichung: | Paris : Elsevier ; <i>Original Publication</i>: Paris : Baillière, [1980-, 2024 |
Medientyp: | academicJournal |
ISSN: | 1768-3122 (electronic) |
DOI: | 10.1016/j.revmed.2023.11.001 |
Schlagwort: |
|
Sonstiges: |
|